Free Trial

Motus GI Q3 2023 Earnings Report

Motus GI logo
$0.0001 0.00 (-50.00%)
(As of 12/20/2024 03:04 PM ET)

Motus GI EPS Results

Actual EPS
-$4.28
Consensus EPS
-$7.20
Beat/Miss
Beat by +$2.92
One Year Ago EPS
N/A

Motus GI Revenue Results

Actual Revenue
$0.09 million
Expected Revenue
$0.13 million
Beat/Miss
Missed by -$40.00 thousand
YoY Revenue Growth
N/A

Motus GI Announcement Details

Quarter
Q3 2023
Time
N/A

Conference Call Resources

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Motus GI Earnings Headlines

Your bank is lying to you.
You might think you have your money in a high-yield savings account, but do you really? The national average APY on savings is just 0.58%, but you can get up to 5.0% APY online with these accounts.
See More Motus GI Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Motus GI? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Motus GI and other key companies, straight to your email.

About Motus GI

Motus GI (NASDAQ:MOTS) operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.

View Motus GI Profile

More Earnings Resources from MarketBeat

Upcoming Earnings